EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Recent Advances and Future Perspectives on Chitosan–Sago-Derived Sodium Starch Glycolate as a Biopolymeric Carrier for Alpha-Mangostin Nanoparticles in Wound Healing

Okta Nama Putra, Ida Musfiroh iD, Amirah Mohd Gazzali, Chaidir Chaidir, Derina Paramitasari, Karjawan Pudjianto, Kusnadi Kusnadi, Taufik Muhammad Fakih iD, Muchtaridi Muchtaridi iD

International Journal of Nanomedicine · 2026

DOI: 10.2147/ijn.s616342 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Nanomedicine, 2026. Verfasst von Okta Nama Putra und 8 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral Program of Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, West Java, Indonesia. Hauptthemen laut MEDLINE: Chitosan, Wound Healing, Xanthones, Nanoparticles. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic wounds remain a major global health challenge, characterized by persistent inflammation, biofilm formation, oxidative stress, and impaired angiogenesis. Despite extensive research on biopolymers and phytochemicals for wound management, an integrated framework that combines agro-derived excipients with nanomedicine-based delivery systems is still limited.

Objective

This review introduces a hybrid carrier strategy combining chitosan and sago-derived sodium starch glycolate (SSG) for the nanoformulation of α-mangostin (α-MG) in chronic wound therapy. The concept integrates biomaterials science and phytopharmaceutical delivery to address both biological and formulation-related challenges.

Methods

A structured literature search was conducted using Scopus, PubMed, and Google Scholar to identify peer-reviewed studies on chitosan-based dressings, SSG functional properties, and α-MG nanoformulations. The findings were critically synthesized to evaluate physicochemical characteristics, biological activities, and translational considerations.

Results

Chitosan provides hemostatic, antibiofilm, and immunomodulatory properties due to its cationic nature, while sago-derived SSG functions as a swelling matrix that regulates hydration and maintains moisture balance. Incorporation of α-MG, known for its antibacterial and antioxidant activity but limited by poor solubility, enables a biphasic delivery profile with an initial antimicrobial effect followed by sustained anti-inflammatory activity. Preclinical evidence indicates improved wound closure, reduced infection risk, and enhanced tissue regeneration.

Conclusion

Chitosan-SSG hybrid systems represent a promising and sustainable platform for α-MG delivery in wound care. This review highlights their synergistic potential and outlines future directions for translational development in chronic wound management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChitosanWound HealingXanthonesNanoparticlesStarchDrug CarriersHumansAnimalsBiopolymers

Stichwörter der Autor:innen

alpha-mangostinbiopolymer carrierchitosan–SSGchronic woundsnanoparticle delivery

Substanzen

mangostinChitosanXanthonesStarchDrug CarriersBiopolymers

Autor:innen und Institutionen

  • Doctoral Program of Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, West Java, Indonesia.
  • Bureau of Organization and Human Resources, National Research and Innovation Agency (BRIN), Jakarta Pusat, Indonesia.
  • Department of Pharmaceutical Analysis and Medicinal Chemistry, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, West Java, Indonesia.
  • School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia.
  • Research Center for Pharmaceutical Ingredient and Traditional Medicine, National Research and Innovation Agency (BRIN), Cibinong, West Java, Indonesia.
  • Research Center for Process Technology, National Research and Innovation Agency (BRIN), South Tangerang, Indonesia.

ORCID-Profile: Ida Musfiroh, Taufik Muhammad Fakih, Muchtaridi Muchtaridi

Zitieren

APA

Putra, O. N., Musfiroh, I., Gazzali, A. M., Chaidir, C., Paramitasari, D., Pudjianto, K., Kusnadi, K., Fakih, T. M., & Muchtaridi, M. (2026). Recent Advances and Future Perspectives on Chitosan–Sago-Derived Sodium Starch Glycolate as a Biopolymeric Carrier for Alpha-Mangostin Nanoparticles in Wound Healing. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s616342

Vancouver

Putra ON, Musfiroh I, Gazzali AM, Chaidir C, Paramitasari D, Pudjianto K, et al. Recent Advances and Future Perspectives on Chitosan–Sago-Derived Sodium Starch Glycolate as a Biopolymeric Carrier for Alpha-Mangostin Nanoparticles in Wound Healing. International Journal of Nanomedicine. 2026. doi:10.2147/ijn.s616342

BibTeX
@article{Putra2026,
  author = {Putra, Okta Nama and Musfiroh, Ida and Gazzali, Amirah Mohd and Chaidir, Chaidir and Paramitasari, Derina and Pudjianto, Karjawan and Kusnadi, Kusnadi and Fakih, Taufik Muhammad and Muchtaridi, Muchtaridi},
  title = {Recent Advances and Future Perspectives on Chitosan–Sago-Derived Sodium Starch Glycolate as a Biopolymeric Carrier for Alpha-Mangostin Nanoparticles in Wound Healing},
  journal = {International Journal of Nanomedicine},
  year = {2026},
  doi = {10.2147/ijn.s616342}
}
Kostenlos starten →